Christopher Regna
About Christopher Regna
Christopher Regna is the Executive Director of Finance for Global Manufacturing Operations at Bristol Myers Squibb, with extensive experience in finance roles across various sectors within the company.
Title: Executive Director Finance Global Mfg Ops
Christopher Regna is the Executive Director of Finance for Global Manufacturing Operations at Bristol Myers Squibb. In this role, he oversees the financial aspects of both internal and external manufacturing operations, focusing on biologics and traditional small molecules. He actively supports business development activities within Global Manufacturing and leads strategic financial initiatives.
Work Experience at Bristol Myers Squibb
Christopher Regna has accumulated extensive experience at Bristol Myers Squibb, holding various leadership roles since 1990. He previously served as Head of Finance for Global Manufacturing and Business Development Support from 2019 to 2021, and as Head of Finance for Biologics Manufacturing & Development from 2014 to 2017. His earlier roles included Director of Finance for Biologics Manufacturing & Process Development, Director of Finance for Capital Planning & Business Development, and multiple managerial positions in cost analysis, customs & trade, and strategic planning.
Education: Fairleigh Dickinson University
Christopher Regna earned a Bachelor's of Science degree in Accounting from Fairleigh Dickinson University, where he studied from 1982 to 1985. This educational foundation provided him with the skills and knowledge required for his extensive career in finance and strategic planning within the pharmaceutical and manufacturing industries.
Key Projects and Initiatives
Christopher Regna played a pivotal role in two major facility projects at Bristol Myers Squibb. He was instrumental in the construction and FDA approval of the Devens, MA large-scale cell culture facility, a project with an investment of approximately $1 billion. Additionally, he oversaw the completion of a large-scale drug substance manufacturing facility in Dublin, Ireland, involving another $1 billion investment. These projects highlight his expertise in large-scale financial management and strategic execution.
Diverse Industry Background
Christopher Regna has a diverse background, having worked in various sectors including specialty chemicals, medical devices, traditional small molecule pharmaceuticals, and large molecule biologics. His experience spans information technology, third-party contract manufacturing, material sourcing, Foreign Trade Zone operations, and US Customs law. This diverse experience contributes to his comprehensive understanding of global manufacturing operations and strategic business processes.